期刊文献+

影响聚乳酸、聚羟基乙酸嵌段共聚物微球中蛋白、多肽类药物释放的因素 被引量:2

下载PDF
导出
摘要 目的介绍蛋白质,多肽类药物聚乳酸(PLA),聚羟基乙酸嵌段共聚物(PLGA)缓释微球近年来的研究进展,特别是影响药物释放的因素。方法根据国内外文献,从4个方面综述了影响生物大分子药物释放的因素,及如何控制突释和保持连续释放方面存在的问题及一些解决的办法。结果与结论聚合物的性质、药物的稳定性、制备工艺和附加剂的存在都会显著的影响微球的释放特性。
出处 《中国药学杂志》 CAS CSCD 北大核心 2006年第14期1049-1052,1062,共5页 Chinese Pharmaceutical Journal
  • 相关文献

参考文献46

  • 1TORRES-LUGO M,PEPPAS N A.Transmucosal delivery systems for calcitonin:a review[J].Biomaterials,2000,21(12):1191-1196.
  • 2MEINEL L,ILLI O E,ZAPFJ,et al.Stabilizing insulin-like growth factor-Ⅰ in poly(D,L-lactide-co-glycolide) microspheres[J].J Controlled Release,2001,70(1-2):193-202.
  • 3SANCHEZ A,TOBIO M,GONZALEZ L,et al.Biodegradable micro-and nanoparticles as long-term delivery vehicles for interferon-alpha[J].Eur J Pharm Sci,2003,18(3-4):221-229.
  • 4WU X S,WANG N.Synthesis,characterization,biodegradation,and drug delivery application of biodegradable lactic/glycolic acid polymers.Part Ⅱ:Biode gradation[J].J Biomater Sci Polym Ed,2001,12(1):21-34.
  • 5OKADA H.One and three month release injectable microspheres of LHRH superagonist leuprorelin acetatel[J].Adv Drug Deliv Rev,1997,28(1):43-70.
  • 6GIOVAGNOLI S,BLASI P,RICCI M,et al.Biodegradable microspheres as carriers for native superoxide dismutase and catalase delivery[J].AAPS Pharm Sci Tech,2004,5(4):51-59.
  • 7HOMAYOUN P,MANDAL T,LANDRY D,et al.Controlled release of anti-cocaine catalytic antibody from biodegradable polymer microspheres[J].J Pharm Pharmacol,2003,55(7):933-938.
  • 8DIAZ R V,LLABRES M,EVORA C.One-month sustained release microspheres of 125I-bovine calcitonin.In vitro-in vivo studies[J].J Controlled Release,1999,59(1):55-62.
  • 9PETTIT D K,LAWTER J R,HUANG W J,et al.Characterization of poly(glycolide co-DL-lactide) /poly(D,L-lactide) microspheres for controlled release of GM-CSF[J].Pharm Res,1997,14(10):1422-1430.
  • 10LAM X M,DUENAS E T,DAUGHERTY A L,et al.Sustained release of recombinant human insulin-like growth factor-Ⅰ for treatment of diabetes[J].J Controlled Release,2000,67(2-3):281-292.

同被引文献29

  • 1金拓.进军国际技术市场是中国医药工业生存与发展的必要条件[J].中国医药工业杂志,2007,38(1). 被引量:3
  • 2宋凤兰,杨帆,张永明,李桃,杨轶群,刘星辰.基因重组人干扰素-α微球的制备及理化性质研究[J].中国药房,2007,18(10):752-754. 被引量:3
  • 3Tan ML,Choong PF,Dass CR.Recent developments in liposomes,microparticles and nanoparticles for protein and peptide drug delivery.Peptides.2010;31(1):184-193.
  • 4Mao S,Xu J,Cai C,et al.Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.Int J Pharm.2007;334(1-2):137-148.
  • 5Raman C,Berkland C,Kim K,et al.Modeling small-molecule release from PLG microspheres:effects of polymer degradation and nonuniform drug distribution.J Control Release.2005;103(1):149-158.
  • 6Giteau A,Venier-Julienne MC,Aubert-Pou?ssel A,et al.How to achieve sustained and complete protein release from PLGA-based microparticles? Int J Pharm.2008;350(1-2):14-26.
  • 7Giunchedi P,Conti B,Genta I,et al.Emulsion spray-drying for the preparation of album in loaded PLGA microspheres.Drug Dev Ind Pharm.2001;27(7):745-750.
  • 8Matsuyama T,Morita T,Horikiri Y,et al.Enhancement of nasal absorption of large molecular weight compounds by combination of mucolytic agent and nonionic surfactant.J Control Release.2006; 110 (2):347-359.
  • 9Paillard-Giteau A,Tran VT,Thomas O,et al.Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique.Eur J Pharm Biopharm.2010;75(2):128-136.
  • 10Hariharan S,Bhardwaj V,Bala I,et al.Design of estradiol loaded PLGA nanoparticulate formulations:a potential oral delivery system for hormone therapy.Pharm Res.2006;23(1):184-195.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部